ask="1.55"
ask_size="800"
average_daily_volume="1437240"
bid="1.33"
bid_size="2100"
book_value="0.61"
change="+0.00"
change_from_200_day_moving_average="0.45"
change_from_50_day_moving_average="0.26"
change_from_52_week_high="-2.95"
change_From_52_week_low="0.75"
change_in_percent="+0.00%"
close="1.38"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.65"
ebitda="-42.12M"
eps_estimate_current_year="-1.50"
eps_estimate_next_quarter="-0.31"
eps_estimate_next_year="-1.45"
ex_dividend_date="N/A"
float_shares="18031000"
high="1.43"
high_52_weeks="4.33"
last_trade_date="3/6/2017"
last_trade_price="1.38"
last_trade_size="586"
last_trade_time="4:00pm"
low="1.32"
low_52_weeks="0.63"
market_capitalization="37.86M"
moving_average_200_day="0.93"
moving_average_50_day="1.12"
name="Cerulean Pharma Inc."
notes="N/A"
one_year_target_price="5.50"
open="1.43"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+48.59%"
percent_change_from_50_day_moving_average="+22.97%"
percent_change_from_52_week_high="-68.13%"
percent_change_from_52_week_low="+118.94%"
previous_close="1.38"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.27"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="27435000"
short_ratio="0.30"
stock_exchange="NGM"
symbol="CERU"
volume="694613"
weeks_range_52="0.63 - 4.33"
